| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Kaymakcalan S |
Tolerance to and dependence on cannabis. |
Bull.Narcotics |
1973 |
| Burstein S, Levin E, Vara... |
Prostaglandins And Cannabis - II. Inhibition Of Biosynthesis By The Na... |
Biochem Pharm |
1973 |
| Segelman AB, Sofia RD |
Cannabis sativa L. (Marijuana) IV: Chemical basis for increased potenc... |
J Pharm Sci |
1973 |
| Munson AE, Harris LS, Fri... |
Antineoplastic activity of cannabinoids |
J Natl Cancer Inst |
1975 |
| Martin P, Consroe P |
Cannabinoid Induced Behavioral Convulsions in Rabbits |
Science |
1976 |
| Szkelyhidi L, Szekelyhidi... |
Psychotomimetic agents Part II. Analytical aspects of psychotomimetics |
Gyógysserészet |
1976 |
| Marshman JA, Popham RE, Y... |
A note on the cannabinoid content of Jamaican ganja |
Bull Narc |
1976 |
| M. Repetto, M. Lopez-Arti... |
Separation of cannabinoids |
Bulletin on Narcotic... |
1976 |
| Moffat A C |
Analytical Chemistry and Drug Metabolism. |
Proc.Anal.Div.Chem.S... |
1978 |
| Fairchild MD, Jenden DJ, ... |
EEG Effects of Hallucinogens and Cannabinoids Using Sleep-Waking Behav... |
Pharmacol. Biochem. ... |
1980 |
| Mechoulam R, Feigenbaum J... |
Enantiomeric cannabinoids: stereospecificity of psychotropic activity |
Experientia |
1988 |
| Martinez, J.A. |
Letters To The Editor |
Journal of Psychoact... |
1988 |
| Herkenham M, Lynn AB, Lit... |
Cannabinoid receptor localization in brain |
Proc Natl Acad Sci U... |
1990 |
| Reggio PH, McGaughey GB, ... |
A rational search for the separation of psychoactivity and analgesia i... |
Pharmacol Biochem Be... |
1991 |
| Devane WA, Breuer A, Shes... |
A novel probe for the cannabinoid receptor |
J Med Chem |
1992 |
| Huestis MA, Henningfield ... |
Blood cannabinoidsIAbsorption of THC and formation of 11-OH-THC and TH... |
J Anal Toxicol |
1992 |
| Devane WA, Axelrod J |
Enzymatic synthesis of anandamide, an endogenous ligand for the cannab... |
Proc Natl Acad Sci U... |
1994 |
| Barrett RL, Wiley JL, Bal... |
Pharmacological specificity of delta 9-tetrahydrocannabinol discrimina... |
Psychopharmacology (... |
1995 |
| Watanabe K, Matsunaga T, ... |
Involvement of CYP2C in the metabolism of cannabinoids by human hepati... |
Biol Pharm Bull |
1995 |
| Shen M, Piser TM, Seybold... |
Cannabinoid receptor agonists inhibit glutamatergic synaptic transmiss... |
J Neurosci |
1996 |
| Gallily R, Yamin A, Waksm... |
Protection against septic shock and suppression of tumor necrosis fact... |
J Pharmacol Exp Ther |
1997 |
| Ros JJ, Pelders MG, Egber... |
Performance of Abusign drugs-of-abuse slide tests with particluar emph... |
J Anal Toxicol |
1998 |
| Moeller MR, Steinmeyer S,... |
Determination of drugs of abuse in blood |
J Chromatogr B Biome... |
1998 |
| Smith FL, Cichewicz D, Ma... |
The enhancement of morphine antinociception in mice by delta9-tetrahyd... |
Pharmacol Biochem Be... |
1998 |
| Gessa GL, Casu MA, Carta ... |
Cannabinoids decrease acetylcholine release in the medial-prefrontal c... |
Eur J Pharmacol |
1998 |
| Gessa GL, Casu MA, Carta ... |
Cannabinoids decrease acetylcholine release in the medial-prefrontal c... |
Eur J Pharmacol |
1998 |
| Shen M, Thayer SA |
Cannabinoid receptor agonists protect cultured rat hippocampal neurons... |
Mol Pharmacol |
1998 |
| Meschler JP, Howlett AC |
Thujone exhibits low affinity for cannabinoid receptors but fails to e... |
Pharmacol Biochem Be... |
1999 |
| Nagayama T, Sinor AD, Sim... |
Cannabinoids and neuroprotection in global and focal cerebral ischemia... |
J Neurosci |
1999 |
| Grotenhermen F |
[Some practice-relevant aspects of the pharmacokinetics of THC] |
Forsch Komplementarm... |
1999 |
| Chin CN, Murphy JW, Huffm... |
The third transmembrane helix of the cannabinoid receptor plays a role... |
J Pharmacol Exp Ther |
1999 |
| Sinor AD, Irvin SM, Green... |
Endocannabinoids protect cerebral cortical neurons from in vitro ische... |
Neurosci Lett |
2000 |
| Galve-Roperh I, Saˇnchez ... |
Anti-tumoral action of cannabinoids: involvement of sustained ceramide... |
Nat Med |
2000 |
| Samyn N, van Haeren C |
On-site testing of saliva and sweat with Drugwipe and determination of... |
Int J Legal Med |
2000 |
| van der Stelt M, Veldhuis... |
Neuroprotection by Delta9-tetrahydrocannabinol, the main active compou... |
J Neurosci |
2001 |
| Mechoulam R, Panikashvili... |
Cannabinoids and brain injury: therapeutic implications |
Trends Mol Med |
2002 |
| Kosel BW, Aweeka FT, Beno... |
The effects of cannabinoids on the pharmacokinetics of indinavir and n... |
AIDS |
2002 |
| Zagnoni PG, Albano C |
Psychostimulants and epilepsy |
Epilepsia |
2002 |
| Moeller MR, Kraemer T |
Drugs of abuse monitoring in blood for control of driving under the in... |
Ther Drug Monit |
2002 |
| Braida D, Sala M |
Role of the endocannabinoid system in MDMA intracerebral self- adminis... |
Br J Pharmacol |
2002 |
| Sena SF, Kazimi S, Wu AH |
False-positive phencyclidine immunoassay results caused by venlafaxine... |
Clin Chem |
2002 |
| Grundy RI |
The therapeutic potential of the cannabinoids in neuroprotection |
Expert Opin Investig... |
2002 |
| van der Stelt M, Veldhuis... |
Acute neuronal injury, excitotoxicity, and the endocannabinoid system |
Mol Neurobiol |
2002 |
| Sidney S |
Cardiovascular consequences of marijuana use |
J Clin Pharmacol |
2002 |
| Zalish M, Lavie V |
Dexanabinol (HU-211) has a beneficial effect on axonal sprouting and s... |
Vision Res |
2003 |
| Brotchie JM |
CB1 cannabinoid receptor signalling in Parkinson's disease |
Curr Opin Pharmacol |
2003 |
| Grotenhermen F |
Pharmacokinetics and pharmacodynamics of cannabinoids |
Clin Pharmacokinet |
2003 |
| Huffman JW, Mabon R, Wu M... |
3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evide... |
Bioorg Med Chem |
2003 |
| Croxford JL |
Therapeutic potential of cannabinoids in CNS disease |
CNS Drugs |
2003 |
| Chemic Labs |
Evaluation Of Volcano® Vaporizer For The Efficient Emission Of THC, CB... |
MAPS.org |
2003 |
| Veldhuis WB, van der Stel... |
Neuroprotection by the endogenous cannabinoid anandamide and arvanil a... |
J Neurosci |
2003 |
| Baker D, Pryce G, Giovann... |
The therapeutic potential of cannabis |
Lancet Neurol |
2003 |
| Grant I, Gonzalez R, Cary... |
Non-acute (residual) neurocognitive effects of cannabis use: A meta-an... |
J Int Neuropsycholog... |
2003 |
| Iversen L |
Cannabis and the brain |
Brain |
2003 |
| van der Stelt M, Hansen H... |
Biosynthesis of endocannabinoids and their modes of action in neurodeg... |
Neurotox Res |
2003 |
| Justinova Z, Tanda G, Red... |
Self-administration of delta9-tetrahydrocannabinol (THC) by drug naive... |
Psychopharmacology (... |
2003 |
| Marsicano G, Goodenough S... |
CB1 cannabinoid receptors and on-demand defense against excitotoxicity |
Science |
2003 |
| Darlington CL |
Dexanabinol: A novel cannabinoid with neuroprotective properties |
IDrugs |
2003 |
| Guzman M |
Cannabinoids: potential anticancer agents |
Nat Rev Cancer |
2003 |
| Leggett JD, Aspley S, Bec... |
Oleamide is a selective endogenous agonist of rat and human CB1 cannab... |
Br J Pharmacol |
2004 |
| Hart S, Fischer OM, Ullri... |
Cannabinoids induce cancer cell proliferation via tumor necrosis facto... |
Cancer Res |
2004 |
| Braida D, Iosue S, Pegori... |
Delta-9-Tetrahydrocannabinol-induced conditioned place preference and ... |
European Journal of ... |
2004 |
| McGilveray IJ |
Pharmacokinetics of cannabinoids |
Pain Res Manag |
2005 |
| Hall PW, Christie PM, Cur... |
Cannabinoids and cancer: causation, remediation, and palliation |
Lancet Oncol |
2005 |
| Ramirez BG, Blazquez C, G... |
Prevention of Alzheimer's disease pathology by cannabinoids: neuroprot... |
J Neurosci |
2005 |
| Sala M, Braida D |
Endocannabinoids and 3,4-methylenedioxymethamphetamine (MDMA) interact... |
Pharmacol Biochem Be... |
2005 |
| Melamede R |
Cannabis and tobacco smoke are not equally carcinogenic |
Harm Reduct J |
2005 |
| Jiang W, Zhang Y, Xiao L,... |
Cannabinoids promote embryonic and adult hippocampus neurogenesis and ... |
J Clin Invest |
2005 |
| Gobbi G, Bambico FR, Mang... |
Antidepressant-like activity and modulation of brain monoaminergic tra... |
pnas |
2005 |
| Ben Amar M |
Cannabinoids in medicine: A review of their therapeutic potential |
J Ethnopharmacol |
2006 |
| Hazekamp, A, Ruhaak, R., ... |
Evaluation of a Vaporizing Device (Volcano®) for the Pulmonary Adminis... |
Journal of Pharmaceu... |
2006 |
| Kim K, Moore DH, Makriyan... |
AM1241, a cannabinoid CB(2) receptor selective compound, delays diseas... |
Eur J Pharmacol |
2006 |
| Parrish JC, Nichols DE |
Serotonin 5-HT(2A) receptor activation induces 2-arachidonoylglycerol ... |
J Neurochem |
2006 |
| Tselnicker I, Keren O, He... |
A single low dose of tetrahydrocannabinol induces long-term cognitive ... |
Neurosci Lett |
2007 |
| Braida D, Limonta V, Pego... |
Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa... |
Psychopharmacology (... |
2007 |
| Haney M |
Opioid Antagonism of Cannabinoid Effects: Differences between Marijuan... |
Neuropsychopharmacol... |
2007 |
| Grinspoon L |
On the future of cannabis as medicine |
Cannabinoids |
2007 |
| Anand JS, Glebocka ML, Ko... |
Recreational abuse with benzydamine hydrochloride (tantum rosa) |
Clin Toxicol (Phila) |
2007 |
| Russo EB |
History of cannabis and its preparations in saga, science, and sobriqu... |
Chem Biodivers |
2007 |
| Bambico FR, Katz N, Debon... |
Cannabinoids elicit antidepressant-like behavior and activate serotone... |
J Neurosci |
2007 |
| Shields LB, Hunsaker Iii ... |
Methadone toxicity fatalities: a review of medical examiner cases in a... |
J Forensic Sci |
2007 |
| Abrams DI, Vizoso HP, Sha... |
Vaporization as a smokeless cannabis delivery system: a pilot study |
Clin Pharmacol Ther |
2007 |
| Moeller KE, Lee KC, Kissa... |
Urine drug screening: practical guide for clinicians |
Mayo Clin Proc |
2008 |
| D'Souza DC, Ranganathan M... |
Blunted Psychotomimetic and Amnestic Effects of Delta-9-Tetrahydrocann... |
Neuropsychopharmacol... |
2008 |
| Senn R, Keren O, Hefetz A... |
Long-term cognitive deficits induced by a single, extremely low dose o... |
Pharmacol Biochem Be... |
2008 |
| Moir D, Rickert WS, Levas... |
A comparison of mainstream and sidestream marijuana and tobacco cigare... |
Chem Res Toxicol |
2008 |
| Morgan CJ, Curran HV |
Effects of cannabidiol on schizophrenia-like symptoms in people who us... |
Br J Psychiatry |
2008 |
| Students T |
Validation of a Gas Chromatography Method for Analysis of Medicinal-Qu... |
erowid |
2008 |
| Neukamm MA, Mürdter TE, W... |
Quantitative determination of the active ’Spice’ ingredient JWH-018 in... |
|
2008 |
| Van der Kooy F, Pomahacov... |
Cannabis smoke condensate I: the effect of different preparation metho... |
Inhal Toxicol |
2008 |
| Grauwiler SB, Drewe J, Sc... |
Sensitivity and specificity of urinary cannabinoid detection with two ... |
Ther Drug Monit |
2008 |
| Appendino G, Gibbons S, G... |
Antibacterial cannabinoids from Cannabis sativa: a structure-activity ... |
J Nat Prod |
2008 |
| Bossong MG, van Berckel B... |
Delta9-Tetrahydrocannabinol Induces Dopamine Release in the Human Stri... |
Neuropsychopharmacol... |
2008 |
| Zuurman L, Roy C, Schoema... |
Effect of intrapulmonary tetrahydrocannabinol administration in humans |
J Psychopharmacol |
2008 |
| Reich CG, Mohammadi MH, A... |
Endocannabinoid modulation of fear responses: learning and state-depen... |
J Psychopharmacol |
2008 |
| Deluca P, Schifano F, Dav... |
Spice Report Psychonaut Web Mapping Research Project |
The Psychonaut Web M... |
2009 |
| Logan BK, Goldfogel G, Ha... |
Five deaths resulting from abuse of dextromethorphan sold over the int... |
J Anal Toxicol |
2009 |
| Uchiyama N, Kikura-Hanaji... |
Identification of a cannabinoid analog as a new type of designer drug ... |
Chem Pharm Bull Toky... |
2009 |
| Salazar M, Carracedo A, S... |
Cannabinoid action induces autophagy-mediated cell death through stimu... |
J Clin Invest |
2009 |
| Mustata C, Torrens M, Par... |
[Spice drugs: cannabinoids as a new designer drugs] |
Adicciones |
2009 |
